Tapering Schedule for Amitriptyline

Introduction to Amitriptyline Use

The American Geriatrics Society recommends amitriptyline for chronic pain conditions, including neuropathic pain, in older adults 1
The American Geriatrics Society also recommends amitriptyline for musculoskeletal pain and headache disorders, including migraine and tension-type headache 1, 2

A gradual tapering schedule over several weeks is recommended to minimize withdrawal symptoms, with dose reductions of approximately 25% every 1-2 weeks until complete discontinuation, as suggested by the American Geriatrics Society 2
The American College of Physicians recommends monitoring for adverse effects during dose reduction, especially in older adults, with a strength of evidence rated as high 3

Older adults have an increased risk of adverse effects from tricyclic antidepressants (TCAs) like amitriptyline, including anticholinergic effects, orthostatic hypotension, and sedation, according to the American Geriatrics Society 2
The American Geriatrics Society recommends careful monitoring during the tapering process, with intervals between dose reductions allowing for adequate observation periods (at least one week at each dose level) 2

The American Geriatrics Society suggests that SNRIs (duloxetine) may be safer than TCAs, particularly in older adults, for headache management 2
The American College of Physicians recommends other preventive options, including propranolol (80-240mg/day) or timolol (20-30mg/day) for migraine, with a strength of evidence rated as moderate 3, 4
The American College of Physicians also recommends NSAIDs like naproxen or ibuprofen for acute treatment of headache, with a strength of evidence rated as high 5
The American Headache Society recommends triptans (sumatriptan, rizatriptan) for acute migraine attacks, with a strength of evidence rated as high 5

The American Geriatrics Society recommends monitoring for adrenergic hyperactivity during the tapering process 2
The American College of Physicians recommends monitoring for sleep disturbances, gastrointestinal symptoms, and mood changes during the tapering process 1, 3, 4

The American College of Physicians recommends scheduling follow-up visits at each dose reduction stage to assess for withdrawal symptoms and pain/headache control, with a strength of evidence rated as moderate 3, 4